Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults - Concepedia

Concepedia

Publication | Open Access

Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults

DOI Full Paper Access

90

Citations

19

References

2010

Year

Joanne M. Langley, Louise Frenette, Linda Ferguson, Dennis Riff, Eric Sheldon, George Risi, Casey Johnson, Ping Li, Richard T. Kenney, Bruce L. Innis,

The Journal of Infectious Diseases

Abstract

Humoral responses against the adjuvanted 3.75-microg hemagglutinin antigen vaccines from both manufacturing sites fulfilled European and US licensure criteria for immunogenicity for influenza vaccines.

References

	Year	Citations

Page 1